The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival
Redmond, C.; Fisher, B.; Wieand, H.S.
Cancer Treatment Reports 67(6): 519-526
1983
ISSN/ISBN: 0361-5960 PMID: 6344993 Document Number: 209319
Document emailed within 1 workday
Related Documents
Markopoulos, M.C.; Lagadas, A.A.; Alexandrou, P.; Giannakopoulos, K.C.; Polyzos, A. 2009: Prolonged disease free survival with aggressive adjuvant chemotherapy in a case of large cell neuroendocrine carcinoma of the uterine cervix Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 322-323Pichatechaiyoot, A.; Buhachat, R.; Boonyapipat, S.; Kanjanapradit, K. 2014: Radiation, chemotherapy or combined modality therapy in adjuvant treatment for stage IIi endometrial carcinoma in lower southern Thailand: disease recurrence and overall survival Journal of the Medical Association of Thailand 97(3): 274-282
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456
2016: (S015) The Impact of Adjuvant Postoperative Radiation Therapy With or Without Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma Oncology 30 Suppl
Taniguchi, H.; Narita, Y.; Komori, K.; Kimura, K.; Kinoshita, T.; Komori, A.; Uegaki, S.; Nomura, M.; Nitta, S.; Yamaguchi, K.; Kadowaki, S.; Takahari, D.; Ura, T.; Andoh, M.; Muro, K. 2015: A questionnaire survey on QOL and toxicity in colorectal cancer survivors who received adjuvant chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(4): 457-461
Tanaka, N.; Matsui, H.; Nagai, Y.; Suzuka, K.; Seki, K.; Sekiya, S. 2002: Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer European Journal of Gynaecological Oncology 23(4): 281-286
Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432
Wenzel, G.; Kuklinski, B.; Rühlmann, C.; Ehrhardt, D. 1993: Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(10): 490-496
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Schetelig, J.; Fetscher, S.; Reichle, A.; Berdel, W.E.; Beguin, Y.; Brunet, S.; Caballero, D.; Majolino, I.; Hagberg, H.; Johnsen, H.E.; Kimby, E.; Montserrat, E.; Stewart, D.; Copplestone, A.; Rösler, W.; Pavel, J.; Kingreen, D.; Siegert, W. 2003: Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation Haematologica 88(11): 1272-1278
Gościński, I. 1997: Craniopharyngioma in childhood. Significance of the extent of surgical resection and adjuvant megavoltage irradiation for event-free survival Neurologia i Neurochirurgia Polska 31(3): 635-636
Anderlini, P.; Ghaddar, H.M.; Smith, T.L.; Pierce, S.; Kantarjian, H.M.; O'Brien, S.; Keating, M.J.; Freireich, E.J.; Estey, E.H. 1996: Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first Leukemia 10(6): 964-969
Indrová, M.; Bieblová, J.; Jandlová, T.án.; Vonka, V.ír.; Pajtasz-Piasecka, E.; Reinis, M. 2006: Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours International Journal of Oncology 28(1): 253-259
Takashi, M.; Murase, T.; Aota, Y.; Nagai, T.; Kinjo, T.; Sabashi, M.; Shimoji, T.; Miyake, K.; Hamajma, N.; Mizuno, S. 1988: Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy Hinyokika Kiyo. Acta Urologica Japonica 34(8): 1377-1381
Zegarac, M.; Nikolic, S.; Gavrilovic, D.; Jevric, M.; Kolarevic, D.; Nikolic-Tomasevic, Z.; Kocic, M.; Djurisic, I.; Inic, Z.; Ilic, V.; Santrac, N. 2013: Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 18(4): 859-865
Sasaki, Y.; Yamagishi, F.; Suzuki, K.; Kuriyama, T. 1997: Survival and pulmonary hemodynamics in patients with sequelae of pulmonary tuberculosis who received home oxygen therapy Nihon Kyobu Shikkan Gakkai Zasshi 35(5): 511-517
Seddik, Y.; Brahmi, S.Aziz.; Afqir, S. 2019: Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study Gulf Journal of Oncology 1(30): 29-32
Hsiao, S-Chuan.; Lin, J-Fen.; Chuang, M-Te.; Lee, Y-An.; Wu, D-Long. 2009: Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer International Surgery 94(4): 298-303
Litviakov, N.V.; Garbukov, E.I.; Slonimskaia, E.M.; Tsyganov, M.M.; Denisov, E.V.; Vtorushin, S.V.; Khristenko, K.I.; Zav'ialova, M.V.; Cherdyntseva, N.V. 2013: Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy Voprosy Onkologii 59(3): 334-340
Stula, N. 1992: Adjuvant cytostatic therapy of breast cancer as an important factor in the postponing of a relapse and longer survival period Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 46(2): 101-111